Once-Monthly Continuous Erythropoietin Receptor Activator (C.E.R.A.) in Patients with Hemodialysis-Dependent Chronic Kidney Disease: Pooled Data from Phase III Trials

INTRODUCTION: Erythropoiesis-stimulating agents and iron are commonly used in patients with chronic kidney disease with the aim of correcting anemia and maintaining stable hemoglobin levels. We analyzed pooled data from 13 studies with similar designs included in the Umbrella Continuous Erythropoiet...

Descripción completa

Detalles Bibliográficos
Autores principales: Locatelli, Francesco, Choukroun, Gabriel, Truman, Matt, Wiggenhauser, Alfons, Fliser, Danilo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846713/
https://www.ncbi.nlm.nih.gov/pubmed/26965694
http://dx.doi.org/10.1007/s12325-016-0309-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846713/
https://www.ncbi.nlm.nih.gov/pubmed/26965694
http://dx.doi.org/10.1007/s12325-016-0309-6

Ejemplares similares